In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 9, p. 2613-2615
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 5, p. 1462-1465
|
In: Journal of Analytical Toxicology, 2005, vol. 29, no. 5, p. 327-338
|
In: European Journal of Clinical Pharmacology, 2009, vol. 65, no. 5, p. 435-442
|
In: Journal of Antimicrobial Chemotherapy, 2011, vol. 66, no. 7, p. 1573-1581
|
In: Clinical Infectious Diseases, 2012, vol. 55, no. 3, p. 381-390
|
In: Scientific Reports, 2019, vol. 9, no. 1, p. 5078
Complementary medicine (CM) is used by one third to one half of cancer patients throughout the world. The objective of this study was to describe the prevalence of CM use and the potential for interactions with cancer treatments in an academic oncology centre. A cross-sectional study was conducted among patients undergoing current cancer treatment. Among 132 included patients, 56% had used CM...
|
In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 12, p. 3413-3422
|
In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 9, p. 2540-2545
|
In: Journal of Antimicrobial Chemotherapy, 2009, vol. 64, no. 3, p. 665-667
|